In particular, the TGF-β-miR-34a-CCL22 pathway-mediated Tregs are shown to enhance the venous transfer of HBV-positive HCC, associated with HCC metastasis and development (Yang et al., 2012). This evidence concerns the gene TGFB1 and hepatocellular carcinoma.